Overexpression of LEDGF/DFS70 induces IL-6 via p38 activation in HaCaT cells, similar to that seen in the psoriatic condition

Journal of Investigative Dermatology

Volumn 130, Issue 12, 2010, Pages 2760-2767

  Takeichi, Takuya ^a   Sugiura, Kazumitsu ^a   Muro, Yoshinao ^a   Matsumoto, Kenji ^b   Ogawa, Yasushi ^a   Futamura, Kyoko ^a,b   Kaminuma, Osamu ^c   Hashimoto, Noriko ^b   Shimoyama, Yoshie ^a   Saito, Hirohisa ^b   Tomita, Yasushi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; CALGRANULIN B; ENHANCED GREEN FLUORESCENT PROTEIN; INTERLEUKIN 6; LENS EPITHELIUM DERIVED GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PSORIASIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPIDERMIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS VULGARIS; RNA INTERFERENCE;

EID: 78149465979     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.203     Document Type: Article

References (46)

1. Ahuja HG, Hong J, Aplan PD et al. (2000) t(9;11)(p22;p15) in acute myeloid leukemia results in a fusion between NUP98 and the gene encoding transcriptional coactivators p52 and p75-lens epithelium-derived growth factor (LEDGF). Cancer Res 60:6227-9
2. Ameglio F, Bonifati C, Fazio M et al. (1997) Interleukin-11 production is increased in organ cultures of lesional skin of patients with active plaque-type psoriasis as compared with nonlesional and normal skin. Similarity to interleukin-1 beta, interleukin-6 and interleukin-8. Arch Dermatol Res 289:399-403
3. Arthur JS, Darragh J (2006) Signaling downstream of p38 in psoriasis. J Invest Dermatol 126:1689-91
4. Battle TE, Frank DA (2002) The role of STATs in apoptosis. Curr Mol Med 2:381-92
5. Bennett BL, Sasaki DT, Murray BW et al. (2001) SP600125, an anthrapyr-azolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98:13681-6
6. Bos JD, de Rie MA, Teunissen MB et al. (2005) Psoriasis: dysregulation of innate immunity. Br J Dermatol 152:1098-107
7. Boukamp P, Petrussevska RT, Breitkreutz D et al. (1988) Normal keratiniza-tion in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-71
8. Bowcock AM, Krueger JG (2005) Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5:699-711
9. Bromberg JF, Wrzeszczynska MH, Devgan G et al. (1999) Stat3 as an oncogene. Cell 98:295-303
10. Broome AM, Ryan D, Eckert RL (2003) S100 protein subcellular localization during epidermal differentiation and psoriasis. J Histochem Cytochem 51:675-85
11. Ciuffi A, Bushman FD (2006) Retroviral DNA integration: HIV and the role of LEDGF/p75. Trends Genet 22:388-95
12. Cohen B, Addadi Y, Sapoznik S et al. (2009) Transcriptional regulation of vascular endothelial growth factor C by oxidative and thermal stress is mediated by lens epithelium-derived growth factor/p75. Neoplasia 11:921-33
13. Cuenda A, Rousseau S (2007) p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 1773:1358-75
14. Daugaard M, Kirkegaard-Sorensen T, Ostenfeld MS et al. (2007) Lens epithelium-derived growth factor is an Hsp70-2 regulated guardian of lysosomal stability in human cancer. Cancer Res 67:2559-67
15. Duncia JV, Santella JB III, Higley CA et al. (1998) MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg Med Chem Lett 8:2839-44
16. Gazel A, Nijhawan RI, Walsh R et al. (2008) Transcriptional profiling defines the roles of ERK and p38 kinases in epidermal keratinocytes. J Cell Physiol 215:292-308
17. Ge H, Si Y, Roeder RG (1998) Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J 17:6723-9
18. Hodge DR, Hurt EM, Farrar WL (2005) The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 41:2502-12
19. Huang TS, Myklebust LM, Kjarland E et al. (2007) LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelo-genic leukemia patients and protects leukemia cells from apoptosis in vitro. Mol Cancer 6:31
20. Hughes S, Jenkins V, Dar MJ et al. (2010) Transcriptional co-activator LEDGF interacts with Cdc7-activator of S-phase kinase (ASK) and stimulates its enzymatic activity. J Biol Chem 285:541-54
21. Iizuka H, Takahashi H, Honma M et al. (2004) Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death. J Dermatol 31:271-6
22. Johansen C, Kragballe K, Rasmussen M et al. (2004) The AP-1 DNA binding activity is decreased in lesional psoriatic skin compared to nonlesional psoriatic skin. Br J Dermatol 151:600-7
23. Johansen C, Kragballe K, Westergaard M et al. (2005) The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br J Dermatol 152:37-42
24. Kramer RM, Roberts EF, Um SL et al. (1996) p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J Biol Chem 271:27723-9
25. Krueger G, Ellis CN (2005) Psoriasis-recent advances in understanding its pathogenesis and treatment. J Am Acad Dermatol 53:S94-100
26. Madsen P, Rasmussen HH, Leffers H et al. (1991) Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin. J Invest Dermatol 97:701-12
27. Maertens G, Cherepanov P, Pluymers W et al. (2003) LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 278:33528-39
28. McKenzie RC, Sabin E (2003) Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis. Exp Dermatol 12:337-45
29. Mediavilla-Varela M, Pacheco FJ, Almaguel F et al. (2009) Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75. Mol Cancer 8:68
30. Muro Y (2001) Autoantibodies in atopic dermatitis. J Dermatol Sci 25:171-8
31. Nguyen TA, Boyle DL, Wagner LM et al. (2003) LEDGF activation of PKC gamma and gap junction disassembly in lens epithelial cells. Exp Eye Res 76:565-72
32. Ochs RL, Muro Y, Si Y et al. (2000) Autoantibodies to DFS70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol 105:1211-20
33. Ogawa Y, Sugiura K, Watanabe A et al. (2004) Autoantigenicity of DFS70 is restricted to the conformational epitope of C-terminal alpha-helical domain. J Autoimmun 23:221-33
34. Okamoto M, Watanabe A, Ogawa Y et al. (2004) Autoantibodies to DFS70/LEDGF are increased in alopecia areata patients. J Autoimmun 23:257-66
35. Qi L, Allen RR, Lu Q et al. (2006) PAI-1 transcriptional regulation during the G0-4G1 transition in human epidermal keratinocytes. J Cell Biochem 99:495-507
36. Sano S, Chan KS, Carbajal S et al. (2005) Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11:43-9
37. Shinohara T, Singh DP, Fatma N (2002) LEDGF, a survival factor, activates stress-related genes. Prog Retin Eye Res 21:341-58
38. Singh DP, Ohguro N, Chylack LT Jr et al. (1999) Lens epithelium derived growth factor: increased resistance to thermal and oxidative stresses. Invest Ophthalmol Vis Sci 40:1444-51
39. Sugiura K, Muro Y (1999) Anti-annexin V antibodies and digital ischemia in patients with scleroderma. J Rheumatol 26:2168-72
40. Sugiura K, Muro Y, Futamura K et al. (2009) The unfolded protein response is activated in differentiating epidermal keratinocytes. J Invest Dermatol 129:2126-35
41. Sugiura K, Muro Y, Nishizawa Y et al. (2007) LEDGF/DFS70, a major autoantigen of atopic dermatitis, is a component of keratohyalin granules. J Invest Dermatol 127:75-80
42. Underwood DC, Osborn RR, Bochnowicz S et al. (2000) SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol Lung Cell Mol Physiol 279:L895-902
43. Verheijen R, Kuijpers HJ, Schlingemann RO et al. (1989) Ki-67 detects a nuclear matrix-associated proliferation-related antigen. I. Intracellular localization during interphase. J Cell Sci 92:123-30
44. Watanabe A, Kodera M, Sugiura K et al. (2004) Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum 50:892-900
45. Yu XJ, Li CY, Dai HY et al. (2007) Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Exp Mol Pathol 83:413-8
46. Zarubin T, Han J (2005) Activation and signaling of the p38 MAP kinase pathway. Cell Res 15:11-8